Alnylam Pharmaceuticals Inc (ALNY.OQ)

ALNY.OQ on NASDAQ Stock Exchange Global Select Market

107.78USD
30 Mar 2015
Change (% chg)

$3.72 (+3.57%)
Prev Close
$104.06
Open
$105.00
Day's High
$107.95
Day's Low
$102.00
Volume
260,153
Avg. Vol
253,111
52-wk High
$121.80
52-wk Low
$47.03

ALNY.OQ

Chart for ALNY.OQ

About

Alnylam Pharmaceuticals, Inc. (Alnylam) is a biopharmaceutical company developing therapeutics based on ribonucleic acid interface (RNAi) in the United States. The Company’s Alnylam 5x15, is focused on the development and commercialization of novel RNAi therapeutics for the treatment of genetically defined diseases. Its core... (more)

Overall

Beta: 1.73
Market Cap(Mil.): $8,740.09
Shares Outstanding(Mil.): 83.99
Dividend: --
Yield (%): --

Financials

  ALNY.OQ Industry Sector
P/E (TTM): -- 137.41 40.78
EPS (TTM): -5.14 -- --
ROI: -53.36 -0.59 16.19
ROE: -59.74 -2.32 17.04
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: ValuEngine, Inc.
$49.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks